ContractResearch Agreement • June 27th, 2014 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • New York
Contract Type FiledJune 27th, 2014 Company Industry Jurisdiction[Pursuant to 17 C.F.R. 240.24b-2, confidential information has been omitted in places marked “[…***…]” and has been filed separately with the Securities and Exchange Commission pursuant to a Confidential Treatment Application.]
RESEARCH AND DEVELOPMENT AGREEMENTResearch and Development Agreement • June 27th, 2014 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • New York
Contract Type FiledJune 27th, 2014 Company Industry JurisdictionTHIS RESEARCH AND DEVELOPMENT AGREEMENT (this “Agreement”), dated as of March 19, 2014 (the “Effective Date”), is made and entered into by and between BioRestorative Therapies, Inc., a Nevada corporation (“BRT”), and Rohto Pharmaceutical Co., Ltd., a Japanese corporation (“Rohto”) (collectively the “Parties” or individually a “Party”).